Sharon Marsh
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism 34
- Oncology top 0.5%
- Drug Transport and Resistance Mechanisms 20
- Colorectal Cancer Treatments and Studies 18
- Cancer Treatment and Pharmacology 7
- Cancer Research top 2%
- Cancer Genomics and Diagnostics 9
- Molecular Biology top 2%
- Cancer therapeutics and mechanisms 18
- Biochemical and Molecular Research 8
-
- Genetic factors in colorectal cancer 8
- Co-authors
- Howard L. McLeodRuss B. AltmanTeri E. KleinCaroline F. ThornConnie OshiroTina Hernandez‐BoussardCristi R. KingAlex Sparreboom
- Cited by
- PharmacologyOncologyCancer Research
- Journals
- Pharmacogenomics (13 papers)Pharmacogenetics and Genomics (7 papers)Clinical Cancer Research (6 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Sharon Marsh
108 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Pharmacology 1.1k
- Oncology 3.0k
- Cancer Research 708
- Molecular Biology 2.9k
- Pathology and Forensic Medicine 587
Countries citing papers authored by Sharon Marsh
This map shows the geographic impact of Sharon Marsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon Marsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon Marsh more than expected).
Fields of papers citing papers by Sharon Marsh
This network shows the impact of papers produced by Sharon Marsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon Marsh. The network helps show where Sharon Marsh may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sharon Marsh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 7 | |
| 2 | 2015 | 5 | |
| 3 | 2015 | 7 | |
| 4 | 2011 | 24 | |
| 5 | Doxorubicin pathwaysbreakdown → | 2010 | 1292 |
| 6 | 2010 | 99 | |
| 7 | 2008 | 73 | |
| 8 | 2008 | 58 | |
| 9 | Methotrexate (MTX) pathway gene polymorphisms and their effects on MTX toxicity in Caucasian and African American patients with rheumatoid arthritis. | 2008 | 126 |
| 10 | 2008 | 3 | |
| 11 | 2007 | 88 | |
| 12 | 2007 | 28 | |
| 13 | 2006 | 48 | |
| 14 | 2005 | 61 | |
| 15 | 2004 | 93 | |
| 16 | 2002 | 328 | |
| 17 | 2001 | 72 | |
| 18 | 2000 | 93 | |
| 19 | 1999 | 69 | |
| 20 | 1999 | 173 |
About Sharon Marsh
Sharon Marsh is a scholar working on Pharmacology, Oncology and Molecular Biology, having authored 109 papers that have together received 6.7k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (34 papers), Drug Transport and Resistance Mechanisms (20 papers), Cancer therapeutics and mechanisms (18 papers), Colorectal Cancer Treatments and Studies (18 papers), Cancer Genomics and Diagnostics (9 papers), Biochemical and Molecular Research (8 papers), Genetic factors in colorectal cancer (8 papers) and Cancer Treatment and Pharmacology (7 papers). The work is most often cited by research in Pharmacology (1.1k citations), Oncology (3.0k citations) and Cancer Research (708 citations). Sharon Marsh has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Howard L. McLeod, Russ B. Altman, Teri E. Klein, Caroline F. Thorn, Connie Oshiro, Tina Hernandez‐Boussard, Cristi R. King, Alex Sparreboom, Jaap Verweij and Ron H.J. Mathijssen. Their work appears in journals such as Pharmacogenomics, Pharmacogenetics and Genomics, Clinical Cancer Research, Human Molecular Genetics and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.